欧洲系统性曲霉病和系统性念珠菌病市场预测至 2027 年 - COVID-19 影响和按类型划分的区域分析（伏立康唑、脂质体、两性霉素 B、系统性口服唑类药物、外用药物、抗真菌药物等）；应用（慢性肺曲霉病 (CPA)、过敏性支气管肺曲霉病 (ABPA)、胃肠道念珠菌病、泌尿生殖道念珠菌病、其他）和国家/地区
No. of Pages: 141 | Report Code: TIPRE00020141 | Category: Life Sciences
No. of Pages: 141 | Report Code: TIPRE00020141 | Category: Life Sciences
真菌全身感染常见于免疫系统较弱的患者，包括免疫抑制和获得性免疫缺陷综合症（艾滋病）患者。全身症状包括呼吸暂停、愈创木脂阳性大便、腹胀、高血糖、类白血病反应、低血压等。系统性念珠菌病和曲霉菌病的治疗需要肠外抗真菌治疗，这种情况的死亡率很高。此外，这种感染可能会导致长期幸存者出现永久性神经发育缺陷。
欧洲系统性曲霉病和系统性念珠菌病市场预计将从 2019 年的 17.026 亿美元增至 2027 年的 22.3755 亿美元；预计 2020 年至 2027 年复合年增长率为 3.5%。欧洲系统性曲霉病和系统性念珠菌病市场的增长归因于真菌疾病患病率的上升以及医院获得性真菌感染的增加。然而，抗真菌药物的耐药性不断增加，抗真菌药物的副作用限制了该地区市场的增长。由于 COVID-19 的不断增长，欧洲国家预计将面临巨大的挑战。受疫情影响，医疗保健行业受到严重影响，产品发布会、产品推介会等众多业务相关活动被推迟，从而制约了市场的增长。
根据类型，欧洲系统性曲霉病和系统性念珠菌病市场分为伏立康唑、脂质体、两性霉素 B、系统性口服唑类药物、外用药物、抗真菌药物、和别的。 2019年，系统性口服唑类药物领域占据了更大的市场份额。预计在预测期内将以更快的速度增长。
在准备欧洲系统性曲霉病和系统性念珠菌病市场报告时提到的一些主要一手和二手来源是世界卫生组织、卫生和预防部以及卫生和家庭福利部。
诺华公司、赛诺菲公司、辉瑞公司、默沙东公司Co., Inc.、拜耳 AG、安斯泰来制药公司、葛兰素史克公司、雅培、Cipla Inc.、Enzon Pharmaceuticals, Inc.。
按类型
按应用
Strategic insights for Europe Systemic Aspergillosis and Systemic Candidasis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,702.60 Million |
| Market Size by 2027 | US$ 2,237.55 Million |
| Global CAGR (2020 - 2027) | 3.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Systemic Aspergillosis and Systemic Candidasis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Systemic Aspergillosis and Systemic Candidasis Market is valued at US$ 1,702.60 Million in 2019, it is projected to reach US$ 2,237.55 Million by 2027.
As per our report Europe Systemic Aspergillosis and Systemic Candidasis Market, the market size is valued at US$ 1,702.60 Million in 2019, projecting it to reach US$ 2,237.55 Million by 2027. This translates to a CAGR of approximately 3.5% during the forecast period.
The Europe Systemic Aspergillosis and Systemic Candidasis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Systemic Aspergillosis and Systemic Candidasis Market report:
The Europe Systemic Aspergillosis and Systemic Candidasis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Systemic Aspergillosis and Systemic Candidasis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Systemic Aspergillosis and Systemic Candidasis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Systemic Aspergillosis and Systemic Candidasis Market
